The Pal3 promoter sequence is critical for the regulation of human renin gene transcription by peroxisome proliferator-activated receptor-γ

Endocrinology

Volumn 149, Issue 9, 2008, Pages 4647-4657

  Todorov, Vladimir T ^a   Desch, Michael ^a   Schubert, Thomas ^a   Kurtz, Armin ^a  

^a UNIVERSITY OF REGENSBURG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

PALINDROMIC DNA; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; PIOGLITAZONE; RENIN; RETINOID X RECEPTOR ALPHA; ROSIGLITAZONE;

ARTICLE; BINDING SITE; CONTROLLED STUDY; GENE; GENE EXPRESSION REGULATION; GENE SEQUENCE; GENETIC TRANSCRIPTION; HORMONE RESPONSIVE ELEMENT; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN MOTIF; RECEPTOR BINDING; RENIN GENE; TRANSCRIPTION INITIATION;

BINDING SITES; CELLS, CULTURED; GENE EXPRESSION REGULATION; GENES, REPORTER; HUMANS; MODELS, BIOLOGICAL; PPAR GAMMA; PROMOTER REGIONS (GENETICS); PROTEIN BINDING; RENIN; RESPONSE ELEMENTS; RNA, SMALL INTERFERING; TANDEM REPEAT SEQUENCES; THIAZOLIDINEDIONES; TRANSCRIPTION, GENETIC; TRANSFECTION;

EID: 50449108231     PISSN: 00137227     EISSN: 00137227     Source Type: Journal    
DOI: 10.1210/en.2008-0127     Document Type: Article

References (46)

1. Skalweit A, Doller A, Huth A, Kahne T, Persson PB, Thiele BJ 2003 Post-transcriptional control of renin synthesis: identification of proteins interacting with renin mRNA 3′-untranslated region. Circ Res 92:419-427
2. Adams DJ, Beveridge DJ, van der Weyden L, Mangs H, Leedman PJ, Morris BJ 2003 HADHB, HuR, and CP1 bind to the distal 3′-untranslated region of human renin mRNA and differentially modulate renin expression. J Biol Chem 278:44894-44903
3. Pan L, Gross KW 2005 Transcriptional regulation of renin: an update. Hypertension 45:3-8
4. Petrovic N, Black TA, Fabian JR, Kane C, Jones CA, Loudon JA, Abonia JP, Sigmund CD, Gross KW 1996 Role of proximal promoter elements in regulation of renin gene transcription. J Biol Chem 271:22499-22505
5. Yan Y, Jones CA, Sigmund CD, Gross KW, Catanzaro DF 1997 Conserved enhancer elements in human and mouse renin genes have different transcriptional effects in As4.1 cells. Circ Res 81:558-566
6. Kobori H, Hayashi M, Saruta T 2001 Thyroid hormone stimulates renin gene expression through the thyroid hormone response element. Hypertension 37:99-104
7. Shi Q, Gross KW, Sigmund CD 2001 Retinoic acid-mediated activation of the mouse renin enhancer. J Biol Chem 276:3597-3603
8. Li YC, Kong J, Wei M, Chen ZF, Liu SQ, Cao LP 2002 1,25-Dihydroxyvitamin D(3) is a negative endocrine regulator of the renin-angiotensin system. J Clin Invest 110:229-238
9. Liu X, Huang X, Sigmund CD 2003 Identification of a nuclear orphan receptor (Ear2) as a negative regulator of renin gene transcription. Circ Res 92:1033-1040
10. Itani HA, Liu X, Pratt JH, Sigmund CD 2007 Functional characterization of polymorphisms in the kidney enhancer of the human renin gene. Endocrinology 148:1424-1430
11. Yuan W, Pan W, Kong J, Zheng W, Szeto FL, Wong KE, Cohen R, Klopot A, Zhang Z, Li YC 2007 1,25-Dihydroxyvitamin D3 suppresses renin gene transcription by blocking the activity of the cyclic AMP response element in the renin gene promoter. J Biol Chem 282:29821-29830
12. Todorov VT, Desch M, Schmitt-Nilson N, Todorova A, Kurtz A 2007 Peroxisome proliferator-activated receptor-γ is involved in the control of renin gene expression. Hypertension 50:939-944
13. Ntambi JM 1999 Regulation of stearoyl-CoA desaturase by polyunsaturated fatty acids and cholesterol. J Lipid Res 40:1549-1558
14. Barroso I, Gurnell M, Crowley VE, Agostini M, Schwabe JW, Soos MA, Maslen GL, Williams TD, Lewis H, Schafer AJ, Chatterjee VK, O'Rahilly S 1999 Dominant negative mutations in human PPARγ associated with severe insulin resistance, diabetes mellitus and hypertension. Nature 402:880-883
15. Tsai YS, Kim HJ, Takahashi N, Kim HS, Hagaman JR, Kim JK, Maeda N 2004 Hypertension and abnormal fat distribution but not insulin resistance in mice with P465L PPARγ. J Clin Invest 114:240-249
16. Duan SZ, Ivashchenko CY, Whitesall SE, D'Alecy LG, Duquaine DC, Brosius FC, Gonzalez FJ, Vinson C, Pierre MA, Milstone DS, Mortensen RM 2007 Hypotension, lipodystrophy, and insulin resistance in generalized PPARγ-deficient mice rescued from embryonic lethality. J Clin Invest 117:812-822
17. Beyer AM, Baumbach GL, Halabi CM, Modrick ML, Lynch CM, Gerhold TD, Ghoneim SM, de Lange WJ, Keen HL, Tsai YS, Maeda N, Sigmund CD, Faraci FM 2008 Interference with PPARγ signaling causes cerebral vascular dysfunction, hypertrophy, and remodeling. Hypertension 51:867-871
18. Halabi CM, Beyer AM, de Lange WJ, Keen HL, Baumbach GL, Faraci FM, Sigmund CD 2008 Interference with PPARγ function in smooth muscle causes vascular dysfunction and hypertension. Cell Metab 7:215-226
19. Willson TM, Lambert MH, Kliewer SA 2001 Peroxisome proliferatoractivated receptor γ and metabolic disease. Annu Rev Biochem 70:341-367
20. Ryan MJ, Didion SP, Mathur S, Faraci FM, Sigmund CD 2004 PPARγ agonist rosiglitazone improves vascular function and lowers blood pressure in hypertensive transgenic mice. Hypertension 43:661-666
21. Okuno M, Arimoto E, Ikenobu Y, Nishihara T, Imagawa M 2001 Dual DNA-binding specificity of peroxisome-proliferator-activated receptor γ controlled by heterodimer formation with retinoid X receptor α. Biochem J 353:193-198
22. Palmer CN, Hsu MH, Griffin HJ, Johnson EF 1995 Novel sequence determinants in peroxisome proliferator signaling. J Biol Chem 270:16114-16121
23. More E, Fellner T, Doppelmayr H, Hauser-Kronberger C, Dandachi N, Obrist P, Sandhofer F, Paulweber B 2003 Activation of the MAP kinase pathway induces chicken ovalbumin upstream promoter-transcription factor II (COUPTFII) expression in human breast cancer cell lines. J Endocrinol 176:83-94
24. Kaiser PC, Korner M, Kappeler A, Aebi S 2005 Retinoid receptors in ovarian cancer: expression and prognosis. Ann Oncol 16:1477-1487
25. Gilad LA, Bresler T, Gnainsky J, Smirnoff P, Schwartz B 2005 Regulation of vitamin D receptor expression via estrogen-induced activation of the ERK 1/2 signaling pathway in colon and breast cancer cells. J Endocrinol 185:577-592
26. Buchanan G, Yang M, Cheong A, Harris JM, Irvine RA, Lambert PF, Moore NL, Raynor M, Neufing PJ, Coetzee GA, Tilley WD 2004 Structural and functional consequences of glutamine tract variation in the androgen receptor. Hum Mol Genet 13:1677-1692
27. Hong SH, Nah HY, Lee YJ, Lee JW, Park JH, Kim SJ, Lee JB, Yoon HS, Kim CH2004 Expression of estrogen receptor-α and -β, glucocorticoid receptor, and progesterone receptor genes in human embryonic stem cells and embryoid bodies. Mol Cells 18:320-325
28. Mrowka R, Steege A, Kaps C, Herzel H, Thiele BJ, Persson PB, Bluthgen N 2007 Dissecting the action of an evolutionary conserved non-coding region on renin promoter activity. Nucleic Acids Res 35:5120-5129
29. Todorov V, Muller M, Schweda F, Kurtz A 2002 Tumor necrosis factor-α inhibits renin gene expression. Am J Physiol Regul Integr Comp Physiol 283:R1046-R1051
30. Todorov VT, Volkl S, Friedrich J, Kunz-Schughart LA, Hehlgans T, Vermeulen L, Haegeman G, Schmitz ML, Kurtz A 2005 Role of CREB1 and NFκB-p65 in the down-regulation of renin gene expression by tumor necrosis factor α. J Biol Chem 280:24356-24362
31. Todorov VT, Volkl S, Muller M, Bohla A, Klar J, Kunz-Schughart LA, Hehlgans T, Kurtz A 2004 Tumor necrosis factor-α activates NFκB to inhibit renin transcription by targeting cAMP-responsive element. J Biol Chem 279:1458-1467
32. Schreiber E, Matthias P, Muller MM, Schaffner W 1989 Rapid detection of octamer binding proteins with 'mini-extracts,' prepared from a small number of cells. Nucleic Acids Res 17:6419
33. Weatherford ET, Itani H, Keen HL, Sigmund CD 2007 Is peroxisome proliferator-activated receptor-γ a new "pal" of renin? Hypertension 50:844-846
34. Chen M, Schnermann J, Smart AM, Brosius FC, Killen PD, Briggs JP 1993 Cyclic AMP selectively increases renin mRNA stability in cultured juxtaglomerular granular cells. J Biol Chem 268:24138-24144
35. Lang JA, Yang G, Kern JA, Sigmund CD 1995 Endogenous human renin expression and promoter activity in CALU-6, a pulmonary carcinoma cell line. Hypertension 25:704-710
36. Lang JA, Ying LH, Morris BJ, Sigmund CD 1996 Transcriptional and post-transcriptional mechanisms regulate human renin gene expression in Calu-6 cells. Am J Physiol 271:F94-F100
37. Ying L, Morris BJ, Sigmund CD 1997 Transactivation of the human renin promoter by the cyclic AMP/protein kinase A pathway is mediated by both cAMP-responsive element binding protein-1 (CREB)-dependent and CREB-independent mechanisms in Calu-6 cells. J Biol Chem 272:2412-2420
38. Castrop H, Oppermann M, Weiss Y, Huang Y, Mizel D, Lu H, Germain S, Schweda F, Theilig F, Bachmann S, Briggs J, Kurtz A, Schnermann J 2006 Reporter gene recombination in juxtaglomerular granular and collecting duct cells by human renin promoter-Cre recombinase transgene. Physiol Genomics 25:277-285
39. Klar J, Vitzthum H, Kurtz A 2004 Aldosterone enhances renin gene expression in juxtaglomerular cells. Am J Physiol Renal Physiol 286:F349-F355
40. Della Bruna R, Kurtz A 1995 Juxtaglomerular cells in culture. Exp Nephrol 3:219-222
41. IJpenberg A, Jeannin E, Wahli W, Desvergne B 1997 Polarity and specific sequence requirements of peroxisome proliferator-activated receptor (PPAR)/retinoid X receptor heterodimer binding to DNA. A functional analysis of the malic enzyme gene PPAR response element. J Biol Chem 272:20108-20117
42. Aranda A, Pascual A 2001 Nuclear hormone receptors and gene expression. Physiol Rev 81:1269-1304
43. Kato S, Sasaki H, Suzawa M, Masushige S, Tora L, Chambon P, Gronemeyer H 1995 Widely spaced, directly repeated PuGGTCA elements act as promiscuous enhancers for different classes of nuclear receptors. Mol Cell Biol 15:5858-5867
44. Barettino D, Bugge TH, Bartunek P, Vivanco Ruiz MD, Sonntag-Buck V, Beug H, Zenke M, Stunnenberg HG 1993 Unliganded T3R, but not its oncogenic variant, v-erbA, suppresses RAR-dependent transactivation by titrating out RXR. EMBO J 12:1343-1354
45. Mangelsdorf DJ, Evans RM 1995 The RXR heterodimers and orphan receptors. Cell 83:841-850
46. Mangelsdorf DJ, Thummel C, Beato M, Herrlich P, Schutz G, Umesono K, Blumberg B, Kastner P, Mark M, Chambon P, Evans RM 1995 The nuclear receptor superfamily: the second decade. Cell 83:835-839